Abstract:BACKGROUND CONTEXT: Numerous factors have been associated with the survival outcomes in patients with spinal cord gliomas (SCG). Recognizing these specific determinants is crucial, yet it is also vital to establish a reliable and precise prognostic model for estimating individual survival outcomes.OBJECTIVE: The objectives of this study are twofold: first, to create an array of interpretable machine learning (ML) models developed for predicting survival outcomes among SCG patients; and second, to integrate these models into an easily navigable online calculator to showcase their prospective clinical applicability.STUDY DESIGN: This was a retrospective, population-based cohort study aiming to predict the outcomes of interest, which were binary categorical variables, in SCG patients with ML models.PATIENT SAMPLE: The National Cancer Database (NCDB) was utilized to identify adults aged 18 years or older who were diagnosed with histologically confirmed SCGs between 2010 and 2019.OUTCOME MEASURES: The outcomes of interest were survival outcomes at three specific time points post-diagnosis: 1, 3, and 5 years. These outcomes were formed by combining the "Vital Status" and "Last Contact or Death (Months from Diagnosis)" variables. Model performance was evaluated visually and numerically. The visual evaluation utilized receiver operating characteristic (ROC) curves, precision-recall curves (PRCs), and calibration curves. The numerical evaluation involved metrics such as sensitivity, specificity, accuracy, area under the PRC (AUPRC), area under the ROC curve (AUROC), and Brier Score.METHODS: We employed five ML algorithms-TabPFN, CatBoost, XGBoost, LightGBM, and Random Forest-along with the Optuna library for hyperparameter optimization. The models that yielded the highest AUROC values were chosen for integration into the online calculator. To enhance the explicability of our models, we utilized SHapley Additive exPlanations (SHAP) for assessing the relative significance of predictor variables and incorporated partial dependence plots (PDPs) to delineate the influence of singular variables on the predictions made by the top performing models.RESULTS: For the 1-year survival analysis, 4,913 patients [5.6% with 1-year mortality]; for the 3-year survival analysis, 4,027 patients (11.5% with 3-year mortality]; and for the 5-year survival analysis, 2,854 patients (20.4% with 5-year mortality) were included. The top models achieved AUROCs of 0.938 for 1-year mortality (TabPFN), 0.907 for 3-year mortality (LightGBM), and 0.902 for 5-year mortality (Random Forest). Global SHAP analyses across survival outcomes at different time points identified histology, tumor grade, age, surgery, radiotherapy, and tumor size as the most significant predictor variables for the top-performing models.CONCLUSIONS: This study demonstrates ML techniques can develop highly accurate prognostic models for SCG patients with excellent discriminatory ability. The interactive online calculator provides a tool for assessment by physicians (https://huggingface.co/spaces/MSHS-Neurosurgery-Research/NCDB-SCG). Local interpretability informs prediction influences for a given individual. External validation across diverse datasets could further substantiate potential utility and generalizability. This robust, interpretable methodology aligns with the goals of precision medicine, establishing a foundation for continued research leveraging ML's predictive power to enhance patient counseling.

Utilizing machine learning to tailor radiotherapy and chemoradiotherapy for low-grade glioma patients

Optimizing adjuvant treatment options for patients with glioblastoma

A Machine Learning‐based Survival Prediction Model of High Grade Glioma by Integration of Clinical and Dose‐volume Histogram Parameters

Individualized survival prediction and surgery recommendation for patients with glioblastoma

Embedding machine learning based toxicity models within radiotherapy treatment plan optimization

1229 Leveraging Machine Learning for Pre-operative Prediction of Supralesional Ablation in Laser Interstitial Thermal Therapy (LITT) for Brain Tumors

Advancing patient care: Machine learning models for predicting grade 3+ toxicities in gynecologic cancer patients treated with HDR brachytherapy

Prediction of treatment response in patients with brain metastasis receiving stereotactic radiosurgery based on pre-treatment multimodal MRI radiomics and clinical risk factors: A machine learning model

A machine learning approach to using Quality-of-Life patient scores in guiding prostate radiation therapy dosing

Developing machine learning models for personalized treatment strategies in early breast cancer patients undergoing neoadjuvant systemic therapy based on SEER database

Improved Prognostication of Overall Survival after Radiotherapy in Lung Cancer Patients by an Interpretable Machine Learning Model Integrating Lung and Tumor Radiomics and Clinical Parameters

Predicting the spatio-temporal response of recurrent glioblastoma treated with rhenium-186 labelled nanoliposomes

Nimg-74. A Novel Approach For Personalized Radiotherapy Target Volume Definition Using Metabolic Mri And Deep Learning-Driven Predictions Of Glioblastoma Recurrence

A meta-learning approach to improving radiation response prediction in cancers

Tailoring nonsurgical therapy for elderly patients with head and neck squamous cell carcinoma: A deep learning-based approach

Personalized Radiotherapy Design for Glioblastoma: Integrating Mathematical Tumor Models, Multimodal Scans and Bayesian Inference

Prognosis Individualized: Survival predictions for WHO grade II and III gliomas with a machine learning-based web application

A method for predictive modeling of tumor regression for lung adaptive radiotherapy

Machine learning in image‐based outcome prediction after radiotherapy: A review

Image-based personalization of computational models for predicting response of high-grade glioma to chemoradiation

Development and internal validation of machine learning models for personalized survival predictions in spinal cord glioma patients